Fundraising Fox

Transition Bio

Cambridge, US · Founded 2020 · Delaware corporation · 4 known investors

Microfluidics and machine learning platform for discovering modulators of biomolecular condensates.

Founders & leadership

TK
Tuomas KnowlesDirector
SC
Samuel CohenDirector
GM
George MartinExecutive Officer, Director
ST
Stephanie TorruellaExecutive Officer
PM
Preet MakkarExecutive Officer
MK
Martin KulanderExecutive Officer
CM
Connor McDermottDirector
GL
Gregory L. MillerExecutive Officer, Director
RW
Robert WeeksDirector
PM
Paxton MajorDirector
KY
Kathy YiDirector
AS
Al SandrockDirector

Investors · 4

Reported raises · per SEC filings

Form D private placements
$13.3MraisedOct 2024 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tuomas KnowlesDirector
  • Kathy YiDirector
  • Robert WeeksDirector
  • George MartinExecutive Officer, Director
  • Al SandrockDirector
  • Stephanie TorruellaExecutive Officer
  • Samuel CohenDirector
  • Preet MakkarExecutive Officer
  • Paxton MajorDirector
Offering amount
$21.3M
Amount sold
$13.3M
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$6MraisedJan 2024 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Samuel CohenDirector
  • Connor McDermottDirector
  • Tuomas KnowlesExecutive Officer, Director
  • George MartinExecutive Officer, Director
  • Preet MakkarExecutive Officer
  • Kathy YiDirector
  • Stephanie TorruellaExecutive Officer
  • Al SandrockDirector
Offering amount
$15M
Amount sold
$6M
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$39.1MraisedMar 2023 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kathy YiDirector
  • Samuel CohenDirector
  • George K. MartinDirector
  • Martin KulanderExecutive Officer
  • Connor McDermottDirector
  • Tuomas KnowlesExecutive Officer
  • Gregory L. MillerExecutive Officer, Director
  • Al SandrockDirector
Offering amount
$50M
Amount sold
$39.1M
First sale
Mar 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.